SF Healthcare Week: Baird Senior Analyst Brian Skorney comments on Monday's conference news and highlights his top picks ahead for 2026
He discusses Biohaven, Xenon, Biogen, and Sarepta.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.